Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Mercia Asset Management Plc LSE:MERC London Ordinary Share GB00BSL71W47 ORD 0.001P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 20.75 60,844 08:00:00
Bid Price Offer Price High Price Low Price Open Price
20.50 21.00 20.75 20.75 20.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 10.68 2.57 0.86 24.1 91
Last Trade Time Trade Type Trade Size Trade Price Currency
15:34:05 O 15 20.99 GBX

Mercia Asset Management (MERC) Latest News

More Mercia Asset Management News
Mercia Asset Management Takeover Rumours

Mercia Asset Management (MERC) Discussions and Chat

Mercia Asset Management Forums and Chat

Date Time Title Posts
01/6/202016:33Mercia Technologies PLC648
01/8/201908:15Mercia Technologies PLC59
29/1/201421:58The new SL500 came today14
24/11/201107:05Merchant Secs37
17/1/201120:21 CHILD FLU VACCINE CONTAINS MERCURY ...ARE PARENTS STUPID?-

Add a New Thread

Mercia Asset Management (MERC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Mercia Asset Management trades in real-time

Mercia Asset Management (MERC) Top Chat Posts

DateSubject
01/6/2020
09:20
Mercia Asset Management Daily Update: Mercia Asset Management Plc is listed in the General Financial sector of the London Stock Exchange with ticker MERC. The last closing price for Mercia Asset Management was 20.75p.
Mercia Asset Management Plc has a 4 week average price of 20.50p and a 12 week average price of 13.50p.
The 1 year high share price is 39p while the 1 year low share price is currently 13.50p.
There are currently 440,109,707 shares in issue and the average daily traded volume is 227,125 shares. The market capitalisation of Mercia Asset Management Plc is £91,322,764.20.
02/5/2020
09:06
wan: Recently Mercia supported and took part in a placing for Concepta at 0.08p. Concepta are indirectly connected with recent Coronavirus developments at Abingdon Health. I note that there has since been a spike in volumes and an increase in Concepta's share price, and yesterday the shares jumped over 30% on strong volume and no news!
28/4/2020
17:51
gwr7: I bought some today. I used a fill or kill order. I'm with wan on this one. Omega Diagnostics is part of the government supported consortium that is developing Point of Care antibody tests to help show the extent of immunity to SARS-CoV-2 in the population. These tests could offer some redemption for a government that took the wrong approach early on and has been scrambling to catch up ever since. The University of Oxford has identified the best allergen to use in the POC test. The partners, including Omega Diagnostics and BBI solutions, will develop and distribute the tests, assuming they are sufficiently accurate. Oxford have been leading on testing the failed antibody kits. There has been a lot of press about the Chinese tests. The government seems to have been held to ransom over these. They agreed to pay up front between £3m and £17m for millions of tests (depending on what you read) that simply don't work. They are no doubt making a claim through paypal. Best of British with that, but it shows how desperate they are for the tests. If they get approval for the POC test, the market could be millions for the UK and possibly billions worldwide as many countries need tests in order to determine who has antibodies, and a bit further down the line, immunity to the SARS-CoV-2 virus. I believe we'll get the working POC test. I've been invested in Omega for four years and I know they have the best experience in the game having developed the world's only semi-quantitive POC test for antibodies on a specific type of T cell in HIV patients. The test estimates a concentration of those T cells in the blood. The covid test is easier in the sense that the first iteration gives a simple yes/no answer to presence of antibodies but the difficulty is achieving the accuracy to keep false positives and negatives to an absolute minimum which is essential for the intended use. The test has to be at least 98% accurate, the higher the better so the top companies in their fields are working on it. I mentioned BBI solutions earlier and they have partnered with the Native Antigen Company based in Oxford. They will be producing antigens for the tests. You can see that if the POC test gets approval that is a big deal for NAC. On a separate though related issue, here is an interesting link hTTps://www.manufacturingchemist.com/news/article_page/BBI_Solutions_partners_to_distribute_COVID-19_antigens_in_China/164520 Omega also has a distribution network in China. Maybe we can show China how to do it! Ideally I would hold shares in NAC but direct ownership is not possible for me. The good news is I know a company that does. Mercia Asset Management have 32.7% Obviously it would be daft to buy in just because of this but they have other promising companies within and without the covid space. I like the way they pick them. Most of the admin costs are covered by the profitable asset management business and they are a lead investment manager for the government’s northern powerhouse initiative. I believe the drive to support quality businesses oop north has legs. Add to that the share price was beaten down by forced sales from Woodford and Invesco funds, and is at a big discount to NAV limiting downside. It looks like a good investment to me. It is definitely long term so it is not going to multi-bag in weeks like other shooting stars of the minute but I believe it will do in time. One of the reasons Woodford failed was that Hargreaves Lansdown were using their promotional fund rankings to funnell investors into his funds who weren’t suited to them. Woodford was the goose that laid the golden egg but that was with high quality income companies. HL turned a blind eye to the investments making up his funds after he set up on his own, and also their open-ended nature. When PIs wanted to withdraw money en masse there wasn’t the liquidity in the smaller companies Woodford had invested in. Redemptions couldn’t be covered without disastrous forced sales. I think Mercia was a good pick by him. Obviously the Mercia share price performance has been poor since launch and that has upset investors. Also they shunned PIs in a discounted placing last year at 25p which forced an apology in the FT so hopefully they learnt from that. Mercia’s investments in companies take time to realise their true value and they need some high profile company sales or IPOs to cement their reputation. I think they’ll achieve them. As ever DYOR.
11/3/2020
16:56
sev22: A new Investment Company has appeared on the share register taking a 5% stake. 'An investment management partnership, Ruffer was founded in 1994. Today, over 300 people work at the firm, and we have offices in London, Edinburgh, Paris, Hong Kong and Guernsey. As at 31 January 2020 we have £19.5 billion in assets under management. Ruffer is a partnership, and this structure aligns our interests with those of our clients. Our senior staff share in the long–term profitability of the firm, so they are interested in investment returns and client relationships that are sustainable over the long haul.' They obviously recognise the value on offer here. I never thought I would see the share price under 20p. According to the house broker Mercia's post-placing NAV is approx 49p, so the shares are less than half price!
02/3/2020
09:16
sev22: Trade 10 was a purchase by me, showing as a sell. Mercia's shares are heavily oversold and I can see material share price upside from here, despite market conditions. Initial price target 30p.
16/1/2020
19:22
pavey ark: https://www.ndreams.com/blog/2019/a-year-in-the-life-of-ndreams/ Hmmmm!! the value of nDreams Han't been increased since 2018 so I would suggest a considerable upgrade is due. nDreams is currently valued at £40m but I suspect they would be looking for a good bit more than that. If the company was sold for £100m then Merc's share would be £37m or exactly the amount contained in the current market cap for the ENTIRE investment portfolio so the rest would be in for free. Perhaps it would be better if people took in the whole thing. https://www.ndreams.com Now: Oxford Genetics, Warwick Acoustics, Medherant, Voxpopme ....anyone? The above is the type of argument put forward By Simon Thompson in the IC before he threw a hissy but the fact that the share price then fell to below the share issue price the argument that PIs lost a chance to participate did lose much of its bite. I agree that the management didn't cover themselves in glory but I care very little about that and I always assume that management will always look after themselves. Anyway....you pays your money and you takes your chance.
16/1/2020
11:12
pavey ark: I've made four separate purchases this morning and increased my holding by 25%.(yes most of those sales are buys) I'm probably done for the moment and have a reasonable holding at a hair under 28p av. I'm saying all this because I always think that it's important that people know where a particular poster is coming from. This company has had a lot to contend with this year and a number of issues of its own making and others beyond its control but having looked at these in some detail and do not consider them material ...certainly not now. Today's announcement is very significant as nDreams is not only the largest constituent in their direct investment portfolio it is in my view the most undervalued. Probably most here are of an age that the developments and potential at nDreams is lost on them but it is very undervalued and a significant premium to the £15m carrying value that must be realised soon. The most recent (and conservative) valuation of the asset management business is 12.2p/share and I make the cash to be 5.6p/share so with 440m shares we have 8.4p/share to cover the direct investment portfolio or £37m. We are now at the point that got me invested here as the most recent (Sept) valuation of the direct investments is £102m. I appreciate that some here are rather disgruntled long term holders who are seriously under water but we are where we are and my point is that it will only take MERC to exit one of their investments at a good profit and the spotlight will fall on the others. There are five or six very good looking candidates for this initial boost and when it happens the share price will certainly respond....well that's my theory!!
03/12/2019
10:45
redartbmud: Payton good at talking the talk, and getting free shares. The share price has been nothing short of a car crash, when are we going to see a positive sustained upward valuation in the share price? Simple question.
28/10/2019
05:14
wan: Brad_K...Mercia has 303m shares in issue (not sure where the other 2-3m came from) - Mercia Technologies PLC Placing of new Ordinary Shares to raise c.£40.0m 31/01/2017 hTTps://uk.advfn.com/stock-market/london/mercia-asset-management-MERC/share-news/Mercia-Technologies-PLC-Placing-of-new-Ordinary-Sh/73735760 16 February 2017 Mercia Technologies PLC Result of General Meeting & Completion of Placing Following Admission, the Company will have 300,602,232 Ordinary shares in issue. hTTps://uk.advfn.com/stock-market/london/mercia-asset-management-MERC/share-news/Mercia-Technologies-PLC-Result-of-General-Meeting/73879386 I seem to recall the CEO saying that going forward Mercia's model would be sustainable i.e. future funding requirements would be provided by a combination of revenues from funds under management and importantly exits.
26/10/2019
05:58
wan: The Woodford AIM shares patient investors should monitor by Andrew Hore from interactive investor | 25th October 2019 Mercia Asset Management (LSE:MERC) has undoubtedly been hit by the overhang. There was a small stake in the investment company, but this appears to have been sold because the remaining 19.99% has all been transferred to Link. The specialist asset manager had a NAV of 41.6p a share at the end of March 2019, whereas the share price has continued to decline and has reached 24.3p. That includes unrestricted cash of £29.8 million – more than one-fifth of NAV. Admittedly, Mercia has a predominantly unquoted portfolio so, just like the Woodford portfolio, the valuation of unquoted companies in the Mercia portfolio could be questioned. Even so, Mercia has a good track record and a 42% discount to NAV is too harsh. Revenues cover nearly 90% of admin expenses. Full article - hTTps://tinyurl.com/Woodford-Mercia
23/10/2019
08:32
brad_k: wan, in your post 263 you seem to have muddled your figures. The 30m Mercia shares equates to 10% of (Mercia) share in issue, as you state, but 50%(approx) of the WIM holding. I think what we are both driving at is that as things stand MERC has a nasty share overhang which could depress the share price for months, some action by the BOD along the lines suggested above would firstly help to reduce that overhang but as you suggest it should also encourage other parties to consider taking a slug of the WIM shares themselves, they would no doubt be getting the shares at a very considerable discount to the new NAV.
Mercia Asset Management share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
MERC
Mercia Ass..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200602 00:11:12